Fairey William
SEC-identified person · CIK 1727275 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Mirum Pharmaceuticals, Inc. MIRM | Director | filed 2021 - 2026 |
| Kalvista Pharmaceuticals, Inc. KALV | Director | filed 2024 - 2026 |
| Ascendis Pharma A/S ASND | Director | filed 2026 - 2026 |
| Rein Therapeutics, Inc. RNTX | Director | filed 2023 - 2025 |
| Myokardia, Inc. MYOK | See Remarks | filed 2019 - 2020 |
| Chemocentryx, Inc. CCXI | Chief Operating Officer | filed 2018 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.